Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Annals of Internal Medicine|November 6, 2002
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapyStephen D Shafran, Laura D Mashinter, Peter Phillips, et al.Iscience|April 19, 2023
COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine seriesSharon L Walmsley, Leah Szadkowski, Bradly Wouters, et al.Plos One|December 10, 2009
Fertility desires and intentions of HIV-positive women of reproductive age in Ontario, Canada: a cross-sectional studyMona R Loutfy, Trevor A Hart, Saira S Mohammed, et al.The Lancet. Infectious Diseases|September 7, 2023
Mpox in people with past infection or a complete vaccination course: a global case seriesAniruddha Hazra, Jason Zucker, Elizabeth Bell, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 25, 2010
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppressionMona R Loutfy, Miguel Genebat, David Moore, et al.HIV Clinical Trials|October 25, 2007
Randomized controlled trial of once-daily tenofovir, lamivudine, and lopinavir/ritonavir versus remaining on the same regimen in virologically suppressed HIV-infected patients on their first PI-containing HAART regimenMona R Loutfy, Nabil Ackad, Tony Antoniou, et al.Vaccine|August 22, 2016
HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccineDeborah M Money, Erin Moses, Sandra Blitz, et al.Trials|July 16, 2020
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, CanadaJulie K Wright, Darrell H S Tan, Sharon L Walmsley, et al.BMJ Open|August 22, 2023
Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohortFelice Cinque, Sahar Saeed, Dana Kablawi, et al.Plos One|July 14, 2022
A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infectionWendy L Wobeser, Joanne E McBane, Louise Balfour, et al.Pageof 14